PROXIMAGEN Trademark

Trademark Overview


On Thursday, September 29, 2005, a trademark application was filed for PROXIMAGEN with the United States Patent and Trademark Office. The USPTO has given the PROXIMAGEN trademark a serial number of 78723291. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, August 7, 2018. This trademark is owned by Proximagen Neuroscience Plc. The PROXIMAGEN trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

[ Pharmaceutical preparations and substances, namely: analgesics; anesthetics, namely, anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics; anti-emetics; antiepileptics; antineuralgics; antipyretics; antirheumatics; antispasmodics; aphrodisiacs; cardiac, cerebral and hepatic restoratives, namely, analgesics, anti-virals, and anti-inflammatories; cardiac sedatives; cardiac stimulants; cerebral depressants; cerebral stimulants; depressants; digestives; diuretics; emetics; hypnotics; motor depressants; motor excitants, namely, amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines; narcotics; nervines; respiratory depressants; respiratory stimulants; sedatives; soporifics, namely, sedatives; stimulants, namely, appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants; vaso-constrictors; vasodilators; and vascular sedatives...

Pharmaceutical research and development services; Product research and development services; Research and development of vaccines and medicines; Research services for others in the fields of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; evaluation and testing of compounds for medical purposes, namely analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, an...

Information services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, eme...
proximagen

General Information


Serial Number78723291
Word MarkPROXIMAGEN
Filing DateThursday, September 29, 2005
Status800 - REGISTERED AND RENEWED
Status DateTuesday, August 7, 2018
Registration Number3431171
Registration DateTuesday, May 20, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2007

Trademark Statements


Goods and Services[ Pharmaceutical preparations and substances, namely: analgesics; anesthetics, namely, anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics; anti-emetics; antiepileptics; antineuralgics; antipyretics; antirheumatics; antispasmodics; aphrodisiacs; cardiac, cerebral and hepatic restoratives, namely, analgesics, anti-virals, and anti-inflammatories; cardiac sedatives; cardiac stimulants; cerebral depressants; cerebral stimulants; depressants; digestives; diuretics; emetics; hypnotics; motor depressants; motor excitants, namely, amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines; narcotics; nervines; respiratory depressants; respiratory stimulants; sedatives; soporifics, namely, sedatives; stimulants, namely, appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants; vaso-constrictors; vasodilators; and vascular sedatives; and pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control ]
Goods and ServicesPharmaceutical research and development services; Product research and development services; Research and development of vaccines and medicines; Research services for others in the fields of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; evaluation and testing of compounds for medical purposes, namely analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives, soporifics, namely sedatives, stimulants, namely appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants, vaso-constrictors, vasodilators, and vascular sedatives in the fields of Research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Licensing of intellectual property; Information services in relation to the fields of research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in the fields of research of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control
Goods and ServicesInformation services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, cardiac, cerebral and hepatic restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, amphetamines, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives, soporifics, namely sedatives, stimulants, namely appetite stimulants, cognitive enhancing agents, namely, neurostimulants, nerve cell growth stimulators and respiratory stimulants, vaso-constrictors, vasodilators, and vascular sedatives; Treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Information services in relation to the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in the fields of treatment of the alimentary tract and metabolism, blood and blood forming-organs, the cardiovascular system, the endocrine system, the musculoskeletal system, the peripheral nervous system, the genitourinary system, the respiratory system, the reproductive system, the central nervous system, the neurological system, and for psychiatric and psychological disorders, neurodegenerative diseases, cancer, and pain relief and control; Advisory and consultation services in relation to analgesics, anesthetics, namely anesthetics for surgical purposes, general anesthetics, local anesthetics, inhalant anesthetics, and topical anesthetics, anti-emetics, antiepileptics, antineuralgics, antipyretics, antirheumatics, antispasmodics, aphrodisiacs, restoratives, namely analgesics, anti-virals, and anti-inflammatories, cardiac sedatives, cardiac stimulants, cerebral depressants, cerebral stimulants, depressants, digestives, diuretics, emetics, hypnotics, motor depressants, motor excitants, namely amphetamines, anti-depressants, and psychomotor stimulants, namely, neurostimulants, narcotics, nervines, respiratory depressants, respiratory stimulants, sedatives; Medical testing and diagnostic services; Provision of medical and pharmaceutical information; and Medical and pharmaceutical consultation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateThursday, June 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2005
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 9, 2007
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePROXIMAGEN, LLC
Party Type33 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressPLYMOUTH, MN 55441

Party NamePROXIMAGEN GROUP LTD.
Party Type32 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressLONDON SE1 1UL
GB

Party NameProximagen Group Limited
Party Type31 - New Owner After Registration
Legal Entity Type24 - NOT AVAILABLE
AddressLondon SE1 IUL
GB

Party NameProximagen Neuroscience Plc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLondon SE1 1UL
GB

Party NameProximagen Neuroscience Plc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon SE1 1UL
GB

Party NameProximagen Neuroscience Plc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon SE1 1UL
GB

Trademark Events


Event DateEvent Description
Wednesday, February 17, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 8, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 7, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, August 7, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, August 7, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, August 3, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, May 20, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, June 5, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 5, 2014REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 20, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, June 4, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 20, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 20, 2008REGISTERED-PRINCIPAL REGISTER
Monday, April 14, 20081(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 9, 2008NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 9, 2008TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 13, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2007NOTICE OF PUBLICATION
Thursday, July 19, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 16, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2007EXAMINER'S AMENDMENT ENTERED
Monday, July 16, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 16, 2007EXAMINERS AMENDMENT E-MAILED
Monday, July 16, 2007EXAMINERS AMENDMENT -WRITTEN
Monday, July 16, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, July 10, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 10, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, July 10, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 10, 2007EXAMINERS AMENDMENT E-MAILED
Tuesday, July 10, 2007EXAMINERS AMENDMENT -WRITTEN
Monday, July 9, 2007EXAMINER'S AMENDMENT ENTERED
Monday, July 9, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 9, 2007EXAMINERS AMENDMENT E-MAILED
Monday, July 9, 2007EXAMINERS AMENDMENT -WRITTEN
Thursday, July 5, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, July 5, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 5, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, July 5, 2007EXAMINERS AMENDMENT -WRITTEN
Friday, June 15, 2007AMENDMENT FROM APPLICANT ENTERED
Friday, June 15, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 7, 2007ASSIGNED TO LIE
Monday, May 21, 2007PAPER RECEIVED
Monday, November 27, 2006NON-FINAL ACTION E-MAILED
Monday, November 27, 2006NON-FINAL ACTION WRITTEN
Friday, November 3, 2006AMENDMENT FROM APPLICANT ENTERED
Wednesday, October 4, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2006PAPER RECEIVED
Thursday, April 6, 2006NON-FINAL ACTION E-MAILED
Thursday, April 6, 2006NON-FINAL ACTION WRITTEN
Monday, April 3, 2006ASSIGNED TO EXAMINER
Thursday, February 16, 2006AMENDMENT FROM APPLICANT ENTERED
Thursday, February 2, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 2, 2006PAPER RECEIVED
Tuesday, October 4, 2005NEW APPLICATION ENTERED IN TRAM